Welcome to our dedicated page for United States Antimony SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
United States Antimony Corporation filings document the public-company record for an antimony, zeolite and critical-minerals producer and processor. Recent 8-K reports cover operating and financial results, conference-call materials, officer and finance-leadership changes, and operational updates tied to the Fostung tungsten property and its Technical Report Summary.
The company’s proxy materials describe annual-meeting voting matters and shareholder governance procedures. Its Form 25 records the withdrawal of common stock from NYSE American following the completed transfer of the listing to the New York Stock Exchange, while later current reports identify UAMY common stock as listed on the NYSE and NYSE Texas. The filings also disclose the company’s common stock class, par value, reporting status, and material-event exhibits.
United States Antimony Corporation is registering an additional 15,000,000 shares of common stock under its Amended and Restated 2023 Equity Incentive Plan. This S-8 filing supports issuing stock-based awards such as options and restricted stock to employees, directors and other service providers.
The Amended and Restated 2023 Plan was approved by shareholders at the 2025 annual meeting on July 31, 2025, and increased the plan’s total share reserve to approximately 23,700,000 shares. As of September 4, 2025, 9,136,201 shares of common stock were subject to outstanding awards and 12,174,767 shares remained available for future grants under the plan.
The prospectus supplement for United States Antimony Corporation (UAMY) discloses that proceeds to the company after expenses and a credit will be $17,605,000. The document notes it was filed with the SEC on April 18, 2025, and describes that offered debt securities may be sold at a fixed price or prices, at prevailing market prices, at prices related to prevailing market prices, or at negotiated prices. No additional financial metrics, use of proceeds details, maturity, interest rates, or underwriting terms are provided in the excerpt.
United States Antimony Corporation appointed General (Ret.) John M. “Jack” Keane to its Board of Directors, effective August 13, 2025. He is a prominent foreign policy and national security authority who advises presidents, cabinet officials, members of congress, international leaders, and business leaders, and serves as Chairman of the Institute for the Study of War and as a member of the Secretary of Defense Policy Board.
General Keane will serve as a director until the next annual meeting of shareholders and until a successor is elected and qualified, or until an earlier death, resignation, or removal. The company states there are no special arrangements or related-party transactions associated with his selection, and his compensation will follow the standard program for non-employee directors. United States Antimony later issued a press release on August 19, 2025 announcing his appointment.
United States Antimony Corporation furnished an update on its recent performance by providing access to a conference call discussing financial and operational results for the second quarter and six months ended June 30, 2025. The call was held on August 12, 2025, and a recorded replay is available on the company’s investor website until August 26, 2025.
The company is also making a written transcript of this conference call available as Exhibit 99.1, which is furnished rather than filed, meaning it is not subject to certain liability provisions of the securities laws and is not automatically incorporated into other SEC filings.
United States Antimony Corporation (UAMY) reported strong year-over-year revenue growth driven by antimony price gains: second-quarter revenue rose to $10,525,123 from $3,662,977 a year earlier and six-month revenue reached $17,525,128 versus $6,735,044. Antimony prices per pound increased sharply (quarterly average $28.32 versus $6.96), which more than offset lower sales volumes and expanded gross profit to $2,837,545 for the quarter and $5,209,275 year-to-date. The company recorded net income of $181,555 for the quarter and $728,079 for the six months.
Balance sheet and cash flow changes reflect an investment and expansion phase: total assets grew to $47,498,322 from $34,642,602, property, plant and equipment rose to $19,725,995, inventories increased to $6,812,527, and the company purchased $9,991,259 of U.S. Treasury Strips. Cash and cash equivalents declined to $5,708,660 from $18,172,120, largely from $17,384,832 used in investing activities including a $5,000,000 acquisition of Ontario mining claims (Fostung Properties) and ongoing claim acquisition commitments. The company also raised capital through stock sales and warrant exercises totaling over $7 million net proceeds year-to-date.
United States Antimony Corporation filed a current report stating that on August 12, 2025 it issued a press release with its financial and operational results. The press release covers the second quarter and six months ended June 30, 2025 and is furnished as Exhibit 99.1 and incorporated by reference.
The company notes that this information is being furnished, not filed under the Exchange Act, which affects how it is treated for certain legal liability purposes. The report is signed on behalf of the company by Richard R. Isaak, Senior Vice President and Chief Financial Officer.
On 31 July 2025 United States Antimony Corporation (NYSE American: UAMY) held its annual shareholders’ meeting and disclosed the final voting results in this Form 8-K (Item 5.07). All five director nominees—Gary C. Evans, Dr. Blaise Aguirre, Lloyd J. Bardswich, Joseph A. Carrabba and Michael A. McManus—were elected for one-year terms ending in 2026.
Shareholders also approved: (1) reincorporation from Montana to Texas (20.6 m for / 11.8 m against / 59 k abstain); (2) the Amended & Restated 2023 Equity Incentive Plan (25.7 m for); (3) an advisory “say-on-pay” resolution (30.5 m for, 1.7 m against); and (4) ratification of Assure CPA, LLC as independent auditor for FY 2025 with 67.1 m for versus 1.1 m against.
While every proposal obtained the required majority, the reincorporation vote shows notable dissent (≈36 % of votes cast). No financial guidance or operating results were provided.
United States Antimony Corp. (NYSE: UAMY) filed an 8-K dated 24 Jul 2025 to disclose completion of its first Technical Report Summary (TRS) for the Bear River Zeolite Project in Preston, Idaho. The TRS, prepared under SEC Regulation S-K sub-part 1300, is provided as Exhibit 96.1; a related press release is Exhibit 99.1. The filing places the disclosure under Item 7.01 (Reg FD) and Item 8.01 (Other Events), meaning the information is furnished—not filed—and therefore carries reduced Exchange Act liability.
The company highlights that the TRS “summarizes the Project’s economic viability under current operating and market conditions,” but the 8-K does not include specific production, reserve, cost, or cash-flow figures. By publishing a compliant TRS, UAMY increases transparency of its zeolite subsidiary, Bear River Zeolite Co., and signals intent to develop or expand the operation. Forward-looking-statement language warns that actual outcomes may differ from current expectations.
No changes to guidance, financial results, or major transactions are reported.